INDOCO REMEDIES
|
The Current P/E Ratio of INDOCO REMEDIES is -22.63.
Share Price | ₹285.0 | Aug 14,2025 |
Market Cap | ₹2,627.2 Cr | |
Earnings-TTM | ₹-116.1 Cr | TTM-Consolidated Results |
Price/Earnings | -22.63x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of INDOCO REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,627.2 Cr] as on Aug 14,2025
(/) Earnings [ ₹-116.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -22.63x ]
Thus, for INDOCO REMEDIES , the investors are currently willing to pay -22.63 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDOCO REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDOCO REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of INDOCO REMEDIES
PE Ratio Performance Analysis for INDOCO REMEDIES
- INDOCO REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 36.57x.
- INDOCO REMEDIES 's operated at median p/e ratio of 28.57x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDOCO REMEDIES 's p/e ratio peaked in Mar2020 at 79.99x.
- INDOCO REMEDIES 's p/e ratio hit its five-year low in Mar2023 of 21.09x.
How does INDOCO REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
INDOCO REMEDIES | -116.10 | -22.63 | 2,627.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.62 | 391,667.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.99 | 163,697.0 |
CIPLA LTD | 5,406.81 | 23.37 | 126,365.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.76 | 123,639.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.42 | 105,479.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.50 | 101,942.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.40 | 99,270.0 |
LUPIN LTD | 3,722.18 | 24.17 | 89,954.1 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.52 | 63,307.4 |
ABBOTT INDIA LTD | 1,452.29 | 47.74 | 69,333.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDOCO REMEDIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -22.63x |
Max industry PE | 70.99x |
Median industry PE | 24.17x |
Average industry PE | 32.26x |
You may also like the below Video Courses